Reviewed,
UniProtKB/Swiss-Prot O75882 (ATRN_HUMAN)
Last modified
December 16, 2008.
Version 93.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Attractin Alternative name(s): Mahogany homolog DPPT-L | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1429 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Involved in the initial immune cell clustering during inflammatory response and may regulate chemotactic activity of chemokines. May play a role in melanocortin signaling pathways that regulate energy homeostasis and hair color. Low-affinity receptor for agouti By similarity. Has a critical role in normal myelination in the central nervous system By similarity. |
| Subcellular location | Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted. Isoform 3: Secreted. |
| Tissue specificity | Expressed and secreted by activated T lymphocytes. Expressed at low to moderate levels in peripheral blood leukocytes, spleen, lymph node, tonsil, bone marrow and fetal liver. At very low levels found in thymus. Isoform 2/secreted is the major isoform in peripheral blood leukocytes. Ref.1 |
| Induction | Activation of peripheral blood leukocytes with phytohemagglutinin induces strong expression of the membrane isoform followed by the release of the secreted isoform. |
| Sequence similarities | Contains 1 C-type lectin domain. Contains 1 CUB domain. Contains 1 EGF-like domain. Contains 6 Kelch repeats. Contains 2 laminin EGF-like domains. |
Ontologies
Keywords | |
|---|---|
| Biological process | Inflammatory response |
| Cellular component | Cell membrane Membrane Secreted |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | EGF-like domain Kelch repeat Laminin EGF-like domain Repeat Signal Transmembrane |
| Ligand | Lectin |
| Molecular function | Receptor |
| PTM | Glycoprotein |
| Technical term | Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | inflammatory response Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | extracellular space Ref.5 Traceable author statement. Source: ProtInc integral to plasma membraneTraceable author statement. Source: ProtInc |
| Molecular function | receptor activity Traceable author statement. Source: ProtInc sugar bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O75882-1) Also known as: Membrane; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O75882-2) Also known as: Secreted; The sequence of this isoform differs from the canonical sequence as follows: 1268-1429: IAFSQHSNFM...QPPAQPGTCI → VQTEQ | ||||||
| Isoform 3 (identifier: O75882-3) The sequence of this isoform differs from the canonical sequence as follows: 31-104: Missing. 1268-1429: IAFSQHSNFM...QPPAQPGTCI → VQTEQ | ||||||
| Notes: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 15 | 15 | Potential | ||||||||
| Chain | 16 – 1429 | 1414 | Attractin | PRO_0000007483 | |||||||
Regions | |||||||||||
| Topological domain | 16 – 1279 | 1264 | Extracellular Potential | ||||||||
| Transmembrane | 1280 – 1300 | 21 | Potential | ||||||||
| Topological domain | 1301 – 1429 | 129 | Cytoplasmic Potential | ||||||||
| Domain | 101 – 129 | 29 | EGF-like | ||||||||
| Domain | 132 – 248 | 117 | CUB | ||||||||
| Repeat | 352 – 402 | 51 | Kelch 1 | ||||||||
| Repeat | 404 – 451 | 48 | Kelch 2 | ||||||||
| Repeat | 461 – 508 | 48 | Kelch 3 | ||||||||
| Repeat | 513 – 564 | 52 | Kelch 4 | ||||||||
| Repeat | 566 – 624 | 59 | Kelch 5 | ||||||||
| Repeat | 625 – 671 | 47 | Kelch 6 | ||||||||
| Domain | 795 – 919 | 125 | C-type lectin | ||||||||
| Domain | 1063 – 1108 | 46 | Laminin EGF-like 1 | ||||||||
| Domain | 1109 – 1157 | 49 | Laminin EGF-like 2 | ||||||||
| Compositional bias | 43 – 77 | 35 | Leu-rich | ||||||||
| Compositional bias | 81 – 89 | 9 | Poly-Ala | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 213 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 237 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 242 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 253 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 264 | 1 | N-linked (GlcNAc...) Ref.7 Ref.8 | ||||||||
| Glycosylation | 300 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 325 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 362 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 383 | 1 | N-linked (GlcNAc...) Ref.7 Ref.8 | ||||||||
| Glycosylation | 416 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 428 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 575 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 623 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 731 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 863 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 914 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 923 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 986 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1043 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 1054 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1073 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1082 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1198 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 1206 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1250 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 1259 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Disulfide bond | 101 ↔ 111 | By similarity | |||||||||
| Disulfide bond | 105 ↔ 118 | By similarity | |||||||||
| Disulfide bond | 120 ↔ 129 | By similarity | |||||||||
| Disulfide bond | 250 ↔ 260 | By similarity | |||||||||
| Disulfide bond | 254 ↔ 271 | By similarity | |||||||||
| Disulfide bond | 273 ↔ 282 | By similarity | |||||||||
| Disulfide bond | 816 ↔ 918 | By similarity | |||||||||
| Disulfide bond | 1063 ↔ 1071 | By similarity | |||||||||
| Disulfide bond | 1065 ↔ 1077 | By similarity | |||||||||
| Disulfide bond | 1080 ↔ 1089 | By similarity | |||||||||
| Disulfide bond | 1092 ↔ 1106 | By similarity | |||||||||
| Disulfide bond | 1127 ↔ 1137 | By similarity | |||||||||
| Disulfide bond | 1140 ↔ 1155 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 31 – 104 | 74 | Missing in isoform 3. | VSP_001372 | |||||||
| Alternative sequence | 1268 – 1429 | 162 | IAFSQ…PGTCI → VQTEQ in isoform 2 and isoform 3. | VSP_001375 | |||||||
| Natural variant | 303 | 1 | D → A: dbSNP rs6107308. | VAR_048967 | |||||||
| Natural variant | 426 | 1 | I → T: dbSNP rs17782078. | VAR_048968 | |||||||
| Natural variant | 1152 | 1 | R → K: dbSNP rs3886999. | VAR_048969 | |||||||
| Natural variant | 1226 | 1 | V → I: dbSNP rs12329487. | VAR_048970 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 69 | 1 | S → P in AAD03057. Ref.2 | ||||||||
| Sequence conflict | 267 | 1 | D → E in AAD03057. Ref.2 | ||||||||
| Sequence conflict | 413 | 1 | S → P in AAD03057. Ref.2 | ||||||||
| Sequence conflict | 1172 | 1 | E → K in AAF72881 and AAF72882. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Secreted and membrane attractin result from alternative splicing of the human ATRN gene." Tang W., Gunn T.M., McLaughlin D.F., Barsh G.S., Schlossman S.F., Duke-Cohan J.S. Proc. Natl. Acad. Sci. U.S.A. 97:6025-6030(2000) [PubMed: 10811918] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, TISSUE SPECIFICITY. |
| [2] | "Cloning of cDNA for attractin-2, identical with that of attractin except for a GC-rich 222 bp 5' insertion." Duke-Cohan J.S., Gu J., Freeman G.J., Schlossman S.F. Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [3] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., |

Clusters with